Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Marcelo C. Pasquini MD, MS

Marcelo C. Pasquini MD, MS

Associate Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Hematology

Member of the Cancer Center


MCW Program / Core Facilities

  • CIBMTR
  • Publications (152)

  • Validation of genetic associations with acute GVHD and nonrelapse mortality in DISCOVeRY-BMT. (Tang H, Hahn T, Karaesmen E, Rizvi AA, Wang J, Paczesny S, Wang T, Preus L, Zhu Q, Wang Y, Haiman CA, Stram D, Pooler L, Sheng X, Van Den Berg D, Brock G, Webb A, Pasquini MC, McCarthy PL, Spellman SR, Sucheston-Campbell LE) Blood Adv 2019 Aug 13;3(15):2337-2341 PMID: 31391166 PMCID: PMC6693017 SCOPUS ID: 2-s2.0-85070778055 08/09/2019    
  • Phase I/II trial of bendamustine, ixazomib, and dexamethasone in relapsed/refractory multiple myeloma. (Dhakal B, D'Souza A, Hamadani M, Arce-Lara C, Schroeder K, Chhabra S, Shah NN, Gauger K, Keaton T, Pasquini M, Hari P) Blood Cancer J 2019 Jul 29;9(8):56 PMID: 31358733 PMCID: PMC6663939 SCOPUS ID: 2-s2.0-85069933026 07/31/2019    
  • Baseline patient-reported outcomes in light-chain amyloidosis patients enrolled on an interventional clinical trial. (D'Souza A, Hari P, Pasquini M, Jacobsen K, Flynn KE) Amyloid 2019;26(sup1):87-88 PMID: 31343353 SCOPUS ID: 2-s2.0-85069630470 07/26/2019    
  • Factors Associated With Unplanned 30-Day Readmissions After Hematopoietic Cell Transplantation Among US Hospitals. (Dhakal B, Giri S, Levin A, Rein L, Fenske TS, Chhabra S, Shah NN, Szabo A, D'Souza A, Pasquini M, Hari P, Hamadani M) JAMA Netw Open 2019 Jul 03;2(7):e196476 PMID: 31276175 SCOPUS ID: 2-s2.0-85068511187 07/06/2019       1 Citation
  • Pulmonary Complications in Pediatric and Adolescent Patients Following Allogeneic Hematopoietic Cell Transplantation. (Broglie L, Fretham C, Al-Seraihy A, George B, Kurtzberg J, Loren A, MacMillan M, Martinez C, Davies SM, Pasquini MC) Biol Blood Marrow Transplant 2019 Oct;25(10):2024-2030 PMID: 31201861 SCOPUS ID: 2-s2.0-85068268605 06/16/2019    
  • Synthetic T2 mapping is correlated with time from stroke onset: a future tool in wake-up stroke management? (Duchaussoy T, Budzik JF, Norberciak L, Colas L, Pasquini M, Verclytte S) Eur Radiol 2019 May 28 PMID: 31139971 05/30/2019    
  • Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement. (McCune JS, Quinones CM, Ritchie J, Carpenter PA, van Maarseveen E, Yeh RF, Anasetti C, Boelens JJ, Hamerschlak N, Hassan M, Kang HJ, Kanda Y, Paci A, Perales MA, Shaw PJ, Seewaldt VL, Savani BN, Hsieh A, Poon B, Mohty M, Pulsipher MA, Pasquini M, Dupuis LL) Biol Blood Marrow Transplant 2019 Sep;25(9):1890-1897 PMID: 31136799 PMCID: PMC6755045 SCOPUS ID: 2-s2.0-85067678155 05/29/2019       1 Citation
  • Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Cell Transplantation Program, Part I: Minimum Requirements and Beyond. (Pasquini MC, Srivastava A, Ahmed SO, Aljurf M, Atsuta Y, Doleysh C, Galeano S, Gluckman E, Greinix H, Hale GA, Hari P, Hashmi SK, Kamani N, Laughlin MJ, Niederwieser D, Seber A, Szer J, Snowden JA, Van Biesen K, Watry P, Weisdorf DJ, Apperley J) Biol Blood Marrow Transplant 2019 May 06 PMID: 31071457 SCOPUS ID: 2-s2.0-85066242026 05/10/2019    
  • Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic Considerations. (Aljurf M, Weisdorf D, Hashmi S, Nassar A, Gluckman E, Mohty M, Rizzo D, Pasquini M, Hamadani M, Saber W, Hari P, Kharfan-Dabaja M, Majhail N, Gerges U, Hamidieh AA, Hussain F, Elhaddad A, Mahmoud HK, Tbakhi A, Othman TB, Hamladji RM, Bekadja MA, Ahmed P, Bazarbachi A, Adil S, Alkindi S, Ladeb S, Dennison D, Patel M, Lu P, Quessar AE, Okamoto S, Atsuta Y, Alhejazi A, Ayas MF, Ahmed SO, Novitzky N, Srivastava A, Seber A, Solh HE, Ghavamzadeh A, Confer D, Kodera Y, Hildegard G, Szer J, Horowitz MM, Niederwieser D) Biol Blood Marrow Transplant 2019 Apr 17 PMID: 31002990 SCOPUS ID: 2-s2.0-85065760511 04/20/2019    
  • Efficacy, Toxicity, and Infectious Complications in Ruxolitinib-Treated Patients with Corticosteroid-Refractory Graft-versus-Host Disease after Hematopoietic Cell Transplantation. (Abedin S, McKenna E, Chhabra S, Pasquini M, Shah NN, Jerkins J, Baim A, Runaas L, Longo W, Drobyski W, Hari PN, Hamadani M) Biol Blood Marrow Transplant 2019 Aug;25(8):1689-1694 PMID: 30965140 SCOPUS ID: 2-s2.0-85065022222 04/10/2019       1 Citation
  • A Phase 2 Study of Pembrolizumab during Lymphodepletion after Autologous Hematopoietic Cell Transplantation for Multiple Myeloma. (D'Souza A, Hari P, Pasquini M, Braun T, Johnson B, Lundy S, Couriel D, Hamadani M, Magenau J, Dhakal B, Shah NN, Riwes M, Parkin B, Reddy P, Pawarode A) Biol Blood Marrow Transplant 2019 Aug;25(8):1492-1497 PMID: 30959163 SCOPUS ID: 2-s2.0-85065451525 04/09/2019       1 Citation
  • Triggers for Atrial Fibrillation: The Role of Anxiety. (Severino P, Mariani MV, Maraone A, Piro A, Ceccacci A, Tarsitani L, Maestrini V, Mancone M, Lavalle C, Pasquini M, Fedele F) Cardiol Res Pract 2019;2019:1208505 PMID: 30906592 PMCID: PMC6398072 03/25/2019    
  • Survival Trends in Infants Undergoing Allogeneic Hematopoietic Cell Transplant. (Parikh SH, Satwani P, Ahn KW, Sahr NA, Fretham C, Abraham AA, Agrawal V, Auletta JJ, Abdel-Azim H, Copelan E, Diaz MA, Dvorak CC, Frangoul HA, Freytes CO, Gadalla SM, Gale RP, George B, Gergis U, Hashmi S, Hematti P, Hildebrandt GC, Keating AK, Lazarus HM, Myers KC, Olsson RF, Prestidge T, Rotz SJ, Savani BN, Shereck EB, Williams KM, Wirk B, Pasquini MC, Loren AW) JAMA Pediatr 2019 May 01;173(5):e190081 PMID: 30882883 PMCID: PMC6503511 SCOPUS ID: 2-s2.0-85062953980 03/19/2019    
  • Comparison of Graft Acquisition and Early Direct Charges of Haploidentical Related Donor Transplantation versus Umbilical Cord Blood Transplantation. (Kanate AS, Szabo A, Raj RV, Bower K, Grulke R, Shah N, Ross KG, Cumpston A, Craig M, Pasquini MC, Shah N, Hari P, Hamadani M, Chhabra S) Biol Blood Marrow Transplant 2019 Jul;25(7):1456-1464 PMID: 30878605 SCOPUS ID: 2-s2.0-85064323899 03/18/2019       1 Citation
  • Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide Conditioning. (McCune JS, Wang T, Bo-Subait K, Aljurf M, Beitinjaneh A, Bubalo J, Cahn JY, Cerny J, Chhabra S, Cumpston A, Dupuis LL, Lazarus HM, Marks DI, Maziarz RT, Norkin M, Prestidge T, Mineishi S, Krem MM, Pasquini M, Martin PJ) Biol Blood Marrow Transplant 2019 Jul;25(7):1424-1431 PMID: 30871976 PMCID: PMC6615968 SCOPUS ID: 2-s2.0-85064251855 03/16/2019    
  • Brief Psychiatric Rating Scale-Expanded (BPRS-E) factor analysis in involuntarily hospitalized psychiatric patients. (Tarsitani L, Ferracuti S, Carabellese F, Catanesi R, Biondi M, Quartesan R, Pasquini M, Mandarelli G) Psychiatry Res 2019 Sep;279:380-381 PMID: 30857882 03/13/2019    
  • Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203). (Bolaños-Meade J, Reshef R, Fraser R, Fei M, Abhyankar S, Al-Kadhimi Z, Alousi AM, Antin JH, Arai S, Bickett K, Chen YB, Damon LE, Efebera YA, Geller NL, Giralt SA, Hari P, Holtan SG, Horowitz MM, Jacobsohn DA, Jones RJ, Liesveld JL, Logan BR, MacMillan ML, Mielcarek M, Noel P, Pidala J, Porter DL, Pusic I, Sobecks R, Solomon SR, Weisdorf DJ, Wu J, Pasquini MC, Koreth J) Lancet Haematol 2019 Mar;6(3):e132-e143 PMID: 30824040 PMCID: PMC6503965 SCOPUS ID: 2-s2.0-85061920512 03/03/2019       6 Citations
  • Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation. (Cohen JA, Baldassari LE, Atkins HL, Bowen JD, Bredeson C, Carpenter PA, Corboy JR, Freedman MS, Griffith LM, Lowsky R, Majhail NS, Muraro PA, Nash RA, Pasquini MC, Sarantopoulos S, Savani BN, Storek J, Sullivan KM, Georges GE) Biol Blood Marrow Transplant 2019 May;25(5):845-854 PMID: 30794930 SCOPUS ID: 2-s2.0-85063110465 02/23/2019       6 Citations
  • "Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries". (Aljurf M, Weisdorf D, Alfraih F, Szer J, Müller C, Confer D, Hashmi S, Kröger N, Shaw BE, Greinix H, Kharfan-Dabaja MA, Foeken L, Seber A, Ahmed S, El-Jawahri A, Al-Awwami M, Atsuta Y, Pasquini M, Hanbali A, Alzahrani H, Okamoto S, Gluckman E, Mohty M, Kodera Y, Horowitz M, Niederwieser D, El Fakih R) Bone Marrow Transplant 2019 Aug;54(8):1179-1188 PMID: 30778127 PMCID: PMC6760540 02/20/2019    
  • Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial. (Stadtmauer EA, Pasquini MC, Blackwell B, Hari P, Bashey A, Devine S, Efebera Y, Ganguly S, Gasparetto C, Geller N, Horowitz MM, Koreth J, Knust K, Landau H, Brunstein C, McCarthy P, Nelson C, Qazilbash MH, Shah N, Vesole DH, Vij R, Vogl DT, Giralt S, Somlo G, Krishnan A) J Clin Oncol 2019 Mar 01;37(7):589-597 PMID: 30653422 PMCID: PMC6553842 SCOPUS ID: 2-s2.0-85064136756 01/18/2019       5 Citations
  • ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells. (Lee DW, Santomasso BD, Locke FL, Ghobadi A, Turtle CJ, Brudno JN, Maus MV, Park JH, Mead E, Pavletic S, Go WY, Eldjerou L, Gardner RA, Frey N, Curran KJ, Peggs K, Pasquini M, DiPersio JF, van den Brink MRM, Komanduri KV, Grupp SA, Neelapu SS) Biol Blood Marrow Transplant 2019 04;25(4):625-638 PMID: 30592986 SCOPUS ID: 2-s2.0-85062342961 12/29/2018       47 Citations
  • Outcomes of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation Performed in the Inpatient versus Outpatient Setting. (Guru Murthy GS, Hari PN, Szabo A, Pasquini M, Narra R, Khan M, Abedin S, Chhabra S, Dhakal B, D'Souza A, Drobyski WR, Rizzo JD, Runaas L, Shah NN, Shaw B, Saber W, Fenske T, Hamadani M) Biol Blood Marrow Transplant 2019 04;25(4):827-833 PMID: 30572109 SCOPUS ID: 2-s2.0-85059680507 12/21/2018       3 Citations
  • The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases. (Thakar MS, Broglie L, Logan B, Artz A, Bunin N, Burroughs LM, Fretham C, Jacobsohn DA, Loren AW, Kurtzberg J, Martinez CA, Mineishi S, Nelson AS, Woolfrey A, Pasquini MC, Sorror ML) Blood 2019 02 14;133(7):754-762 PMID: 30545834 PMCID: PMC6376282 SCOPUS ID: 2-s2.0-85061488564 12/14/2018       3 Citations
  • Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation. (Brunstein CG, Pasquini MC, Kim S, Fei M, Adekola K, Ahmed I, Aljurf M, Agrawal V, Auletta JJ, Battiwalla M, Bejanyan N, Bubalo J, Cerny J, Chee L, Ciurea SO, Freytes C, Gadalla SM, Gale RP, Ganguly S, Hashmi SK, Hematti P, Hildebrandt G, Holmberg LA, Lahoud OB, Landau H, Lazarus HM, de Lima M, Mathews V, Maziarz R, Nishihori T, Norkin M, Olsson R, Reshef R, Rotz S, Savani B, Schouten HC, Seo S, Wirk BM, Yared J, Mineishi S, Rogosheske J, Perales MA) Biol Blood Marrow Transplant 2019 03;25(3):480-487 PMID: 30423481 PMCID: PMC6445718 SCOPUS ID: 2-s2.0-85058228349 11/14/2018    
  • Summary of the Second Annual BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling. (Holstein SA, Ye JC, Howard A, Bhutani M, Gormley N, Hahn T, Hillengass J, Krishnan A, Landgren CO, Munshi NC, Oliva S, Owen RG, Pasquini MC, Puig N, Weinhold N, Weisel K, McCarthy PL) Biol Blood Marrow Transplant 2019 03;25(3):e89-e97 PMID: 30408566 PMCID: PMC6445685 SCOPUS ID: 2-s2.0-85057956613 11/09/2018       2 Citations
  • Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends. (Baldomero H, Aljurf M, Zaidi SZA, Hashmi SK, Ghavamzadeh A, Elhaddad A, Hamladji RM, Ahmed P, Torjemane L, Abboud M, Tbakhi A, Khabori MA, El Quessar A, Bazuaye N, Bekadja MA, Adil S, Fahmy O, Ramzi M, Ibrahim A, Alseraihy A, Ben Abdejalil N, Sarhan M, Huneini MA, Mahmal L, ElSolh H, Hussain F, Nassar A, Al-Hashmi H, Hamidieh AA, Pasquini M, Kodera Y, Kröger N, Mohty M, Jaimovich G, Rolon JM, Paulson K, Greinix H, Weisdorf D, Horowitz M, Nunez J, Gratwohl A, Passweg J, Koh M, Szer J, Niederwieser D, Novitzky N, East-Mediterranean (EMBMT) and African (AfBMT) Blood and Marrow Transplantation Groups and the Worldwide Network for Blood and Marrow Transplantation (WBMT)) Bone Marrow Transplant 2019 Mar;54(3):402-417 PMID: 30082852 PMCID: PMC6363888 SCOPUS ID: 2-s2.0-85052538993 08/08/2018       4 Citations
  • Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation. (Sullivan KM, Majhail NS, Bredeson C, Carpenter PA, Chatterjee S, Crofford LJ, Georges GE, Nash RA, Pasquini MC, Sarantopoulos S, Storek J, Savani B, St Clair EW) Biol Blood Marrow Transplant 2018 10;24(10):1961-1964 PMID: 29953945 PMCID: PMC6239926 SCOPUS ID: 2-s2.0-85054357023 06/29/2018       13 Citations
  • Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant. (Strouse C, Zhang Y, Zhang MJ, DiGilio A, Pasquini M, Horowitz MM, Lee S, Ho V, Ramanathan M, Chinratanalab W, Loren A, Burns LJ, Artz A, Villa KF, Saber W) Biol Blood Marrow Transplant 2018 10;24(10):2072-2080 PMID: 29928989 PMCID: PMC6239945 SCOPUS ID: 2-s2.0-85054166744 06/22/2018       5 Citations
  • Reply to the persistent uncertainty of when to recommend allogeneic stem cell transplantation in follicular iymphoma. (Sureda A, Montoto S, Dreger P, Hamadani M, Pasquini MC) Cancer 2018 08;124(16):3455-3456 PMID: 29878309 SCOPUS ID: 2-s2.0-85052190185 06/08/2018    
  • Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine. (Harris AC, Boelens JJ, Ahn KW, Fei M, Abraham A, Artz A, Dvorak C, Frangoul H, Freytes C, Gale RP, Hong S, Lazarus HM, Loren A, Mineishi S, Nishihori T, O'Brien T, Williams K, Pasquini MC, Levine JE) Blood Adv 2018 06 12;2(11):1198-1206 PMID: 29844205 PMCID: PMC5998928 SCOPUS ID: 2-s2.0-85060322942 05/31/2018       1 Citation
  • Pharmacokinetics of High-Dose Propylene Glycol-Free Melphalan in Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation. (Dhakal B, D'Souza A, Lakshman A, Hamadani M, Chhabra S, Thompson R, Shah N, Pasquini M, Hari P) Biol Blood Marrow Transplant 2018 08;24(8):1610-1614 PMID: 29751116 SCOPUS ID: 2-s2.0-85048069667 05/12/2018       2 Citations
  • Rationale and design of DUAL study: Doxycycline to Upgrade response in light chain (AL) amyloidosis (DUAL): A phase 2 pilot study of a two-pronged approach of prolonged doxycycline with plasma cell-directed therapy in the treatment of AL amyloidosis. (D'Souza A, Flynn K, Chhabra S, Dhakal B, Hamadani M, Jacobsen K, Pasquini M, Weihrauch D, Hari P) Contemp Clin Trials Commun 2017 Dec;8:33-38 PMID: 29696194 PMCID: PMC5898504 SCOPUS ID: 2-s2.0-85027981960 04/27/2018    
  • Peripheral Blood Grafts for T Cell-Replete Haploidentical Transplantation Increase the Incidence and Severity of Cytokine Release Syndrome. (Raj RV, Hamadani M, Szabo A, Pasquini MC, Shah NN, Drobyski WR, Shaw BE, Saber W, Rizzo JD, Jerkins J, Fenske TS, D'Souza A, Dhakal B, Zhang C, Konings S, Hari PN, Chhabra S) Biol Blood Marrow Transplant 2018 08;24(8):1664-1670 PMID: 29680516 SCOPUS ID: 2-s2.0-85047194888 04/24/2018       10 Citations
  • Use of propylene glycol-free melphalan conditioning in light-chain amyloidosis patients undergoing autologous hematopoietic cell transplantation is well tolerated and effective. (Badar T, Hari P, Chhabra S, Dhakal B, Drobyski WR, Fenske TS, Hamadani M, Pasquini M, Saber W, Shah NN, Shaw BE, D'Souza A) Bone Marrow Transplant 2018 09;53(9):1210-1213 PMID: 29679076 SCOPUS ID: 2-s2.0-85045751124 04/22/2018       2 Citations
  • Exome chip analyses identify genes affecting mortality after HLA-matched unrelated-donor blood and marrow transplantation. (Zhu Q, Yan L, Liu Q, Zhang C, Wei L, Hu Q, Preus L, Clay-Gilmour AI, Onel K, Stram DO, Pooler L, Sheng X, Haiman CA, Zhu X, Spellman SR, Pasquini M, McCarthy PL, Liu S, Hahn T, Sucheston-Campbell LE) Blood 2018 05 31;131(22):2490-2499 PMID: 29610366 PMCID: PMC5981168 SCOPUS ID: 2-s2.0-85048119147 04/04/2018       4 Citations
  • Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR. (Sureda A, Zhang MJ, Dreger P, Carreras J, Fenske T, Finel H, Schouten H, Montoto S, Robinson S, Smith SM, Boumedil A, Hamadani M, Pasquini MC) Cancer 2018 04 15;124(8):1733-1742 PMID: 29424927 PMCID: PMC5946312 SCOPUS ID: 2-s2.0-85041530897 02/10/2018       8 Citations
  • Survival of Lymphoma Patients Experiencing Relapse or Progression after an Allogeneic Hematopoietic Cell Transplantation. (Epperla N, Hamadani M, Ahn KW, He F, Kodali D, Kleman A, Hari PN, Pasquini M, Fenske TS, Craig MD, Kanate AS, Bachanova V) Biol Blood Marrow Transplant 2018 05;24(5):983-988 PMID: 29410340 SCOPUS ID: 2-s2.0-85042234569 02/08/2018       2 Citations
  • Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft--host disease: low incidence of lower gastrointestinal tract disease. (Drobyski WR, Szabo A, Zhu F, Keever-Taylor C, Hebert KM, Dunn R, Yim S, Johnson B, D'Souza A, Eapen M, Fenske TS, Hari P, Hamadani M, Horowitz MM, Rizzo JD, Saber W, Shah N, Shaw B, Pasquini M) Haematologica 2018 04;103(4):717-727 PMID: 29351985 PMCID: PMC5865423 SCOPUS ID: 2-s2.0-85044420638 01/21/2018       4 Citations
  • Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials. (Pasquini MC, Logan B, Jones RJ, Alousi AM, Appelbaum FR, Bolaños-Meade J, Flowers MED, Giralt S, Horowitz MM, Jacobsohn D, Koreth J, Levine JE, Luznik L, Maziarz R, Mendizabal A, Pavletic S, Perales MA, Porter D, Reshef R, Weisdorf D, Antin JH) Biol Blood Marrow Transplant 2018 06;24(6):1274-1280 PMID: 29325830 PMCID: PMC5993573 SCOPUS ID: 2-s2.0-85041672720 01/13/2018       10 Citations
  • Genetic association with B-cell acute lymphoblastic leukemia in allogeneic transplant patients differs by age and sex. (Clay-Gilmour AI, Hahn T, Preus LM, Onel K, Skol A, Hungate E, Zhu Q, Haiman CA, Stram DO, Pooler L, Sheng X, Yan L, Liu Q, Hu Q, Liu S, Battaglia S, Zhu X, Block AW, Sait SNJ, Karaesmen E, Rizvi A, Weisdorf DJ, Ambrosone CB, Tritchler D, Ellinghaus E, Ellinghaus D, Stanulla M, Clavel J, Orsi L, Spellman S, Pasquini MC, McCarthy PL, Sucheston-Campbell LE) Blood Adv 2017 Sep 12;1(20):1717-1728 PMID: 29296818 PMCID: PMC5728332 01/04/2018    
  • BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee. (Holstein SA, Avet-Loiseau H, Hahn T, Ho CM, Lohr JG, Munshi NC, Paiva B, Pasquini MC, Tario JD Jr, Usmani SZ, Wallace PK, Weisel K, McCarthy PL) Biol Blood Marrow Transplant 2018 04;24(4):641-648 PMID: 29242112 PMCID: PMC5902638 SCOPUS ID: 2-s2.0-85040518117 12/16/2017       3 Citations
  • Cell-based therapeutic strategies for multiple sclerosis. (Scolding NJ, Pasquini M, Reingold SC, Cohen JA, International Conference on Cell-Based Therapies for Multiple Sclerosis, International Conference on Cell-Based Therapies for Multiple Sclerosis, International Conference on Cell-Based Therapies for Multiple Sclerosis) Brain 2017 11 01;140(11):2776-2796 PMID: 29053779 PMCID: PMC5841198 SCOPUS ID: 2-s2.0-85032909723 10/21/2017       43 Citations
  • Presence of fluorescent in situ hybridization abnormalities is associated with plasma cell burden in light chain amyloidosis. (Hammons L, Brazauskas R, Pasquini M, Hamadani M, Hari P, D'Souza A) Hematol Oncol Stem Cell Ther 2018 Jun;11(2):105-111 PMID: 28830801 SCOPUS ID: 2-s2.0-85027963716 08/24/2017       1 Citation
  • Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial. (Holstein SA, Jung SH, Richardson PG, Hofmeister CC, Hurd DD, Hassoun H, Giralt S, Stadtmauer EA, Weisdorf DJ, Vij R, Moreb JS, Callander NS, van Besien K, Gentile TG, Isola L, Maziarz RT, Bashey A, Landau H, Martin T, Qazilbash MH, Rodriguez C, McClune B, Schlossman RL, Smith SE, Hars V, Owzar K, Jiang C, Boyd M, Schultz C, Wilson M, Hari P, Pasquini MC, Horowitz MM, Shea TC, Devine SM, Linker C, Anderson KC, McCarthy PL) Lancet Haematol 2017 Sep;4(9):e431-e442 PMID: 28826616 PMCID: PMC5718627 SCOPUS ID: 2-s2.0-85027488718 08/23/2017       23 Citations
  • Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant. (Karaesmen E, Rizvi AA, Preus LM, McCarthy PL, Pasquini MC, Onel K, Zhu X, Spellman S, Haiman CA, Stram DO, Pooler L, Sheng X, Zhu Q, Yan L, Liu Q, Hu Q, Webb A, Brock G, Clay-Gilmour AI, Battaglia S, Tritchler D, Liu S, Hahn T, Sucheston-Campbell LE) Blood 2017 09 28;130(13):1585-1596 PMID: 28811306 PMCID: PMC5620418 SCOPUS ID: 2-s2.0-85030025781 08/16/2017       16 Citations
  • Etanercept and Corticosteroid Therapy for the Treatment of Late-Onset Idiopathic Pneumonia Syndrome. (Thompson J, Yin Z, D'Souza A, Fenske T, Hamadani M, Hari P, Rizzo JD, Pasquini M, Saber W, Shah N, Shaw BE, Shahir K, Banerjee A, Drobyski WR) Biol Blood Marrow Transplant 2017 Nov;23(11):1955-1960 PMID: 28757436 SCOPUS ID: 2-s2.0-85028446880 08/02/2017       1 Citation
  • Cost and quality issues in establishing hematopoietic cell transplant program in developing countries. (Hashmi SK, Srivastava A, Rasheed W, Adil S, Wu T, Jagasia M, Nassar A, Hwang WYK, Hamidieh AA, Greinix HT, Pasquini MC, Apperley JF, Aljurf M) Hematol Oncol Stem Cell Ther 2017 Dec;10(4):167-172 PMID: 28732192 SCOPUS ID: 2-s2.0-85026291965 07/22/2017       7 Citations
  • Alpha-1-antitrypsin for the treatment of steroid-refractory acute gastrointestinal graft-versus-host disease. (Jerkins JH, Hamadani M, Zook F, Epperla N, Shaw BE, Saber W, Rizzo JD, Pasquini M, Chhabra S, Drobyski WR, Hari PN, Shah NN) Am J Hematol 2017 Oct;92(10):E610-E611 PMID: 28699171 SCOPUS ID: 2-s2.0-85026445343 07/13/2017       2 Citations
  • Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States. (Muffly L, Pasquini MC, Martens M, Brazauskas R, Zhu X, Adekola K, Aljurf M, Ballen KK, Bajel A, Baron F, Battiwalla M, Beitinjaneh A, Cahn JY, Carabasi M, Chen YB, Chhabra S, Ciurea S, Copelan E, D'Souza A, Edwards J, Foran J, Freytes CO, Fung HC, Gale RP, Giralt S, Hashmi SK, Hildebrandt GC, Ho V, Jakubowski A, Lazarus H, Luskin MR, Martino R, Maziarz R, McCarthy P, Nishihori T, Olin R, Olsson RF, Pawarode A, Peres E, Rezvani AR, Rizzieri D, Savani BN, Schouten HC, Sabloff M, Seftel M, Seo S, Sorror ML, Szer J, Wirk BM, Wood WA, Artz A) Blood 2017 08 31;130(9):1156-1164 PMID: 28674027 PMCID: PMC5580273 SCOPUS ID: 2-s2.0-85028876059 07/05/2017       52 Citations
  • Trends in pre- and post-transplant therapies with first autologous hematopoietic cell transplantation among patients with multiple myeloma in the United States, 2004-2014. (D'Souza A, Zhang MJ, Huang J, Fei M, Pasquini M, Hamadani M, Hari P) Leukemia 2017 09;31(9):1998-2000 PMID: 28663578 PMCID: PMC5587375 SCOPUS ID: 2-s2.0-85028872119 07/01/2017       7 Citations
  • Current Use and Trends in Hematopoietic Cell Transplantation in the United States. (D'Souza A, Lee S, Zhu X, Pasquini M) Biol Blood Marrow Transplant 2017 Sep;23(9):1417-1421 PMID: 28606646 PMCID: PMC5565685 SCOPUS ID: 2-s2.0-85023159496 06/14/2017       47 Citations
  • Latin America: the next region for haematopoietic transplant progress. (Jaimovich G, Rolon JM, Baldomero H, Rivas M, Hanesman I, Bouzas L, Bonfim C, Palma J, Kardus-Urueta A, Ubidia D, Bujan-Boza W, Gonzalez-Ramella O, Ruiz-Argüelles G, Gomez-Almaguer D, Espino G, Fanilla E, Gonzalez D, Carrasco A, Galeano S, Borelli G, Hernandez-Gimenez M, Pasquini M, Kodera Y, Gratwohl A, Gratwohl M, Nuñez J, Szer J, Gale RP, Niederwieser D, Seber A) Bone Marrow Transplant 2017 05;52(5):798 PMID: 28465623 05/04/2017    
  • Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic Transplantation. (Kanate AS, Hari PN, Pasquini MC, Visotcky A, Ahn KW, Boyd J, Guru Murthy GS, Rizzo JD, Saber W, Drobyski W, Michaelis L, Atallah E, Carlson KS, D'Souza A, Fenske TS, Cumpston A, Bunner P, Craig M, Horowitz MM, Hamadani M) Biol Blood Marrow Transplant 2017 Aug;23(8):1295-1302 PMID: 28412518 SCOPUS ID: 2-s2.0-85019639994 04/17/2017       3 Citations
  • Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes. (Scott BL, Pasquini MC, Logan BR, Wu J, Devine SM, Porter DL, Maziarz RT, Warlick ED, Fernandez HF, Alyea EP, Hamadani M, Bashey A, Giralt S, Geller NL, Leifer E, Le-Rademacher J, Mendizabal AM, Horowitz MM, Deeg HJ, Horwitz ME) J Clin Oncol 2017 Apr 10;35(11):1154-1161 PMID: 28380315 PMCID: PMC5455603 SCOPUS ID: 2-s2.0-85017300040 04/06/2017       129 Citations
  • Evaluation of the Pharmacokinetics and Efficacy of a Busulfan Test Dose in Adult Patients Undergoing Myeloablative Hematopoietic Cell Transplantation. (Weil E, Zook F, Oxencis C, Canadeo A, Urmanski A, Waggoner M, Eastwood D, Pasquini M, Hamadani M, Hari P) Biol Blood Marrow Transplant 2017 Jun;23(6):952-957 PMID: 28288949 SCOPUS ID: 2-s2.0-85017516033 03/16/2017       9 Citations
  • Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis. (Muraro PA, Pasquini M, Atkins HL, Bowen JD, Farge D, Fassas A, Freedman MS, Georges GE, Gualandi F, Hamerschlak N, Havrdova E, Kimiskidis VK, Kozak T, Mancardi GL, Massacesi L, Moraes DA, Nash RA, Pavletic S, Ouyang J, Rovira M, Saiz A, Simoes B, Trnený M, Zhu L, Badoglio M, Zhong X, Sormani MP, Saccardi R, Multiple Sclerosis–Autologous Hematopoietic Stem Cell Transplantation (MS-AHSCT) Long-term Outcomes Study Group) JAMA Neurol 2017 Apr 01;74(4):459-469 PMID: 28241268 PMCID: PMC5744858 SCOPUS ID: 2-s2.0-85015108062 02/28/2017       62 Citations
  • Autologous Hematopoietic Cell Transplantation in Patients With Multiple Myeloma: Effect of Age. (Dhakal B, Nelson A, Guru Murthy GS, Fraser R, Eastwood D, Hamadani M, Pasquini M, D'Souza A, Hari P) Clin Lymphoma Myeloma Leuk 2017 03;17(3):165-172 PMID: 28159578 SCOPUS ID: 2-s2.0-85011032026 02/06/2017       9 Citations
  • Latin America: the next region for haematopoietic transplant progress. (Jaimovich G, Martinez Rolon J, Baldomero H, Rivas M, Hanesman I, Bouzas L, Bonfim C, Palma J, Kardus-Urueta A, Ubidia D, Bujan-Boza W, Gonzalez-Ramella O, Ruiz-Argüelles G, Gomez-Almaguer D, Espino G, Fanilla E, Gonzalez D, Carrasco A, Galeano S, Borelli G, Hernandez-Gimenez M, Pasquini M, Kodera Y, Gratwohl A, Gratwohl M, Nuñez J, Szer J, Gale RP, Niederwieser D, Seber A) Bone Marrow Transplant 2017 May;52(5):671-677 PMID: 28112744 SCOPUS ID: 2-s2.0-85010867668 01/24/2017       11 Citations
  • The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes. (Artz AS, Logan B, Zhu X, Akpek G, Bufarull RM, Gupta V, Lazarus HM, Litzow M, Loren A, Majhail NS, Maziarz RT, McCarthy P, Popat U, Saber W, Spellman S, Ringden O, Wickrema A, Pasquini MC, Cooke KR, from the Center for International Blood and Marrow Transplantation Research) Haematologica 2016 11;101(11):1426-1433 PMID: 27662010 PMCID: PMC5394859 SCOPUS ID: 2-s2.0-84994651188 11/02/2016       21 Citations
  • Replication of associations between genetic polymorphisms and chronic graft-versus-host disease. (Martin PJ, Fan W, Storer BE, Levine DM, Zhao LP, Warren EH, Flowers ME, Lee SJ, Carpenter PA, Boeckh M, Hingorani S, Yan L, Hu Q, Preus L, Liu S, Spellman S, Zhu X, Pasquini M, McCarthy P, Stram D, Sheng X, Pooler L, Haiman CA, Sucheston-Campbell L, Hahn T, Hansen JA) Blood 2016 11 17;128(20):2450-2456 PMID: 27758874 PMCID: PMC5114491 SCOPUS ID: 2-s2.0-85015663767 10/21/2016       10 Citations
  • Impact of haploidentical hematopoietic cell transplantation conditioning intensity on the incidence and severity of post-transplantation viral infections. (Raj RV, Hari P, Pasquini M, Epperla N, D'Souza A, Fenske T, Shaw BE, Rizzo JD, Drobyski W, Hamadani M) Bone Marrow Transplant 2016 12;51(12):1602-1604 PMID: 27595288 SCOPUS ID: 2-s2.0-84991038636 09/07/2016       3 Citations
  • Salvage haploidentical hematopoietic cell transplantation for graft rejection following a prior haploidentical allograft. (Epperla N, Pasquini M, Pierce K, Drobyski WR, Rizzo JD, Horowitz MM, Saber W, Zellner K, Ramirez S, Bartz K, Raj RV, Hari PN, Hamadani M) Bone Marrow Transplant 2017 01;52(1):147-150 PMID: 27479688 SCOPUS ID: 2-s2.0-84980370503 08/02/2016       2 Citations
  • Hematopoietic Progenitor Cell Mobilization with Ifosfamide, Carboplatin, and Etoposide Chemotherapy versus Plerixafor-Based Strategies in Patients with Hodgkin and Non-Hodgkin Lymphoma. (Dhakal B, Veltri LW, Fenske TS, Eastwood D, Craig MD, Cumpston A, Shillingburg A, Esselman J, Watkins K, Pasquini MC, D'Souza A, Hari P, Kanate AS, Hamadani M) Biol Blood Marrow Transplant 2016 10;22(10):1773-1780 PMID: 27345140 SCOPUS ID: 2-s2.0-84992043960 06/28/2016       2 Citations
  • Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative study. (D'Souza A, Pasquini M, Logan B, Giralt S, Krishnan A, Antin J, Howard A, Goodman S, Qazilbash M, Knust K, Sahebi F, Weisdorf D, Vesole D, Stadtmauer E, Maloney D, Hari P) Br J Haematol 2017 09;178(5):816-819 PMID: 27292583 PMCID: PMC5154782 SCOPUS ID: 2-s2.0-84994285799 06/14/2016       2 Citations
  • Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Impact of Disease Risk and Post Allograft Minimal Residual Disease on Survival. (Dhakal B, D'Souza A, Martens M, Kapke J, Harrington AM, Pasquini M, Saber W, Drobyski WR, Zhang MJ, Hamadani M, Hari PN) Clin Lymphoma Myeloma Leuk 2016 07;16(7):379-86 PMID: 27160644 SCOPUS ID: 2-s2.0-84965053091 05/11/2016       3 Citations
  • Intravenous Busulfan-Based Myeloablative Conditioning Regimens Prior to Hematopoietic Cell Transplantation for Hematologic Malignancies. (Pasquini MC, Le-Rademacher J, Zhu X, Artz A, DiPersio J, Fernandez HF, Mineishi S, Kamishohara M, Mehta J, Nakamura Y, Ratanatharathorn V, Sobecks R, Burkart J, Bredeson C) Biol Blood Marrow Transplant 2016 08;22(8):1424-1430 PMID: 27154848 PMCID: PMC4949158 SCOPUS ID: 2-s2.0-84981328222 05/08/2016       9 Citations
  • Identifying existing Choosing Wisely recommendations of high relevance and importance to hematology. (Hicks LK, Rajasekhar A, Bering H, Carson KR, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Panepinto JA, Pasquini MC, Sarode R, Wood WA) Am J Hematol 2016 08;91(8):787-92 PMID: 27152483 SCOPUS ID: 2-s2.0-84978252396 05/07/2016       4 Citations
  • Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes. (Flowers CR, Costa LJ, Pasquini MC, Le-Rademacher J, Lill M, Shore TB, Vaughan W, Craig M, Freytes CO, Shea TC, Horwitz ME, Fay JW, Mineishi S, Rondelli D, Mason J, Braunschweig I, Ai W, Yeh RF, Rodriguez TE, Flinn I, Comeau T, Yeager AM, Pulsipher MA, Bence-Bruckler I, Laneuville P, Bierman P, Chen AI, Kato K, Wang Y, Xu C, Smith AJ, Waller EK) Biol Blood Marrow Transplant 2016 07;22(7):1197-1205 PMID: 27040394 PMCID: PMC4914052 SCOPUS ID: 2-s2.0-84975229745 04/05/2016       7 Citations
  • Haematopoietic cell transplants in Latin America. (Gale RP, Seber A, Bonfim C, Pasquini M) Bone Marrow Transplant 2016 Jul;51(7):898-905 PMID: 26999468 PMCID: PMC4935585 SCOPUS ID: 2-s2.0-84961391147 03/22/2016       8 Citations
  • DAS181 Treatment of Severe Parainfluenza Virus 3 Pneumonia in Allogeneic Hematopoietic Stem Cell Transplant Recipients Requiring Mechanical Ventilation. (Dhakal B, D'Souza A, Pasquini M, Saber W, Fenske TS, Moss RB, Drobyski WR, Hari P, Abidi MZ) Case Rep Med 2016;2016:8503275 PMID: 26941799 PMCID: PMC4749780 03/05/2016    
  • Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey. (Niederwieser D, Baldomero H, Szer J, Gratwohl M, Aljurf M, Atsuta Y, Bouzas LF, Confer D, Greinix H, Horowitz M, Iida M, Lipton J, Mohty M, Novitzky N, Nunez J, Passweg J, Pasquini MC, Kodera Y, Apperley J, Seber A, Gratwohl A) Bone Marrow Transplant 2016 Jun;51(6):778-85 PMID: 26901703 PMCID: PMC4889523 SCOPUS ID: 2-s2.0-84959109035 02/24/2016       106 Citations
  • Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions. (Kumar R, Kimura F, Ahn KW, Hu ZH, Kuwatsuka Y, Klein JP, Pasquini M, Miyamura K, Kato K, Yoshimi A, Inamoto Y, Ichinohe T, Wood WA Jr, Wirk B, Seftel M, Rowlings P, Marks DI, Schultz KR, Gupta V, Dedeken L, George B, Cahn JY, Szer J, Lee JW, Ho AY, Fasth A, Hahn T, Khera N, Dalal J, Bonfim C, Aljurf M, Atsuta Y, Saber W) Biol Blood Marrow Transplant 2016 May;22(5):932-40 PMID: 26797402 PMCID: PMC4826285 SCOPUS ID: 2-s2.0-84963704520 01/23/2016       11 Citations
  • Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese Populations. (Kanda J, Brazauskas R, Hu ZH, Kuwatsuka Y, Nagafuji K, Kanamori H, Kanda Y, Miyamura K, Murata M, Fukuda T, Sakamaki H, Kimura F, Seo S, Aljurf M, Yoshimi A, Milone G, Wood WA, Ustun C, Hashimi S, Pasquini M, Bonfim C, Dalal J, Hahn T, Atsuta Y, Saber W) Biol Blood Marrow Transplant 2016 Apr;22(4):744-751 PMID: 26762681 PMCID: PMC4801761 SCOPUS ID: 2-s2.0-84960476841 01/15/2016       17 Citations
  • Global Use of Peripheral Blood vs Bone Marrow as Source of Stem Cells for Allogeneic Transplantation in Patients With Bone Marrow Failure. (Yoshimi A, Baldomero H, Horowitz M, Szer J, Niederwieser D, Gratwohl A, Kodera Y, Worldwide Network of Blood and Marrow Transplantation (WBMT)) JAMA 2016 Jan 12;315(2):198-200 PMID: 26757470 01/13/2016       10 Citations
  • Safety of ruxolitinib therapy prior to allogeneic hematopoietic stem-cell transplantation for myeloproliferative neoplasms. (Hanif A, Hari PN, Atallah E, Carlson KS, Pasquini MC, Michaelis LC) Bone Marrow Transplant 2016 Apr;51(4):617-8 PMID: 26726940 SCOPUS ID: 2-s2.0-84953295752 01/05/2016       4 Citations
  • One million haemopoietic stem-cell transplants: a retrospective observational study. (Gratwohl A, Pasquini MC, Aljurf M, Atsuta Y, Baldomero H, Foeken L, Gratwohl M, Bouzas LF, Confer D, Frauendorfer K, Gluckman E, Greinix H, Horowitz M, Iida M, Lipton J, Madrigal A, Mohty M, Noel L, Novitzky N, Nunez J, Oudshoorn M, Passweg J, van Rood J, Szer J, Blume K, Appelbaum FR, Kodera Y, Niederwieser D, Worldwide Network for Blood and Marrow Transplantation (WBMT)) Lancet Haematol 2015 Mar;2(3):e91-100 PMID: 26687803 SCOPUS ID: 2-s2.0-84930322558 12/22/2015       126 Citations
  • Monocyte recovery at day 100 is associated with improved survival in multiple myeloma patients who undergo allogeneic hematopoietic cell transplantation. (Dhakal B, Brazauskas R, Lara CA, Hari P, Pasquini M, D'Souza A) Bone Marrow Transplant 2016 Feb;51(2):297-9 PMID: 26457907 PMCID: PMC4956087 SCOPUS ID: 2-s2.0-84956915976 10/13/2015       2 Citations
  • American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma. (Giralt S, Garderet L, Durie B, Cook G, Gahrton G, Bruno B, Hari P, Lokhorst H, McCarthy P, Krishnan A, Sonneveld P, Goldschmidt H, Jagannath S, Barlogie B, Mateos M, Gimsing P, Sezer O, Mikhael J, Lu J, Dimopoulos M, Mazumder A, Palumbo A, Abonour R, Anderson K, Attal M, Blade J, Bird J, Cavo M, Comenzo R, de la Rubia J, Einsele H, Garcia-Sanz R, Hillengass J, Holstein S, Johnsen HE, Joshua D, Koehne G, Kumar S, Kyle R, Leleu X, Lonial S, Ludwig H, Nahi H, Nooka A, Orlowski R, Rajkumar V, Reiman A, Richardson P, Riva E, San Miguel J, Turreson I, Usmani S, Vesole D, Bensinger W, Qazilbash M, Efebera Y, Mohty M, Gasparreto C, Gajewski J, LeMaistre CF, Bredeson C, Moreau P, Pasquini M, Kroeger N, Stadtmauer E) Biol Blood Marrow Transplant 2015 Dec;21(12):2039-2051 PMID: 26428082 PMCID: PMC4757494 SCOPUS ID: 2-s2.0-84947430469 10/03/2015       76 Citations
  • Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies. (Pasquini MC, Zhang MJ, Medeiros BC, Armand P, Hu ZH, Nishihori T, Aljurf MD, Akpek G, Cahn JY, Cairo MS, Cerny J, Copelan EA, Deol A, Freytes CO, Gale RP, Ganguly S, George B, Gupta V, Hale GA, Kamble RT, Klumpp TR, Lazarus HM, Luger SM, Liesveld JL, Litzow MR, Marks DI, Martino R, Norkin M, Olsson RF, Oran B, Pawarode A, Pulsipher MA, Ramanathan M, Reshef R, Saad AA, Saber W, Savani BN, Schouten HC, Ringdén O, Tallman MS, Uy GL, Wood WA Jr, Wirk B, Pérez WS, Batiwalla M, Weisdorf DJ) Biol Blood Marrow Transplant 2016 Feb;22(2):248-257 PMID: 26327629 PMCID: PMC4716890 SCOPUS ID: 2-s2.0-84958573214 09/04/2015       17 Citations
  • Changes in cardiac biomarkers with bortezomib treatment in patients with advanced cardiac amyloidosis. (Hussain AS, Hari P, Brazauskas R, Arce-Lara C, Pasquini M, Hamadani M, D'Souza A) Am J Hematol 2015 Nov;90(11):E212-3 PMID: 26284951 PMCID: PMC4618044 SCOPUS ID: 2-s2.0-84944536944 08/19/2015       5 Citations
  • Establishment of Definitions and Review Process for Consistent Adjudication of Cause-specific Mortality after Allogeneic Unrelated-donor Hematopoietic Cell Transplantation. (Hahn T, Sucheston-Campbell LE, Preus L, Zhu X, Hansen JA, Martin PJ, Yan L, Liu S, Spellman S, Tritchler D, Clay A, Onel K, Pasquini M, McCarthy PL) Biol Blood Marrow Transplant 2015 Sep;21(9):1679-1686 PMID: 26028504 PMCID: PMC4537799 SCOPUS ID: 2-s2.0-84938961741 06/02/2015       10 Citations
  • Bortezomib-based induction for transplant ineligible AL amyloidosis and feasibility of later transplantation. (Cornell RF, Zhong X, Arce-Lara C, Atallah E, Blust L, Drobyski WR, Fenske TS, Pasquini MC, Rizzo JD, Saber W, Hari PN) Bone Marrow Transplant 2015 Jul;50(7):914-7 PMID: 25915809 SCOPUS ID: 2-s2.0-84934862607 04/29/2015       13 Citations
  • Safety of outpatient autologous hematopoietic cell transplantation for multiple myeloma and lymphoma. (Graff TM, Singavi AK, Schmidt W, Eastwood D, Drobyski WR, Horowitz M, Palmer J, Pasquini M, Rizzo DJ, Saber W, Hari P, Fenske TS) Bone Marrow Transplant 2015 Jul;50(7):947-53 PMID: 25867651 PMCID: PMC4490016 SCOPUS ID: 2-s2.0-84934795677 04/14/2015       13 Citations
  • Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study. (Sorror ML, Logan BR, Zhu X, Rizzo JD, Cooke KR, McCarthy PL, Ho VT, Horowitz MM, Pasquini MC) Biol Blood Marrow Transplant 2015 Aug;21(8):1479-87 PMID: 25862591 PMCID: PMC4512746 SCOPUS ID: 2-s2.0-84937713457 04/12/2015       61 Citations
  • The Sequence of Cyclophosphamide and Myeloablative Total Body Irradiation in Hematopoietic Cell Transplantation for Patients with Acute Leukemia. (Holter-Chakrabarty JL, Pierson N, Zhang MJ, Zhu X, Akpek G, Aljurf MD, Artz AS, Baron F, Bredeson CN, Dvorak CC, Epstein RB, Lazarus HM, Olsson RF, Selby GB, Williams KM, Cooke KR, Pasquini MC, McCarthy PL) Biol Blood Marrow Transplant 2015 Jul;21(7):1251-7 PMID: 25840335 PMCID: PMC4465990 SCOPUS ID: 2-s2.0-84930576712 04/04/2015       5 Citations
  • Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies. (Olsson RF, Logan BR, Chaudhury S, Zhu X, Akpek G, Bolwell BJ, Bredeson CN, Dvorak CC, Gupta V, Ho VT, Lazarus HM, Marks DI, Ringdén OT, Pasquini MC, Schriber JR, Cooke KR) Leukemia 2015 Aug;29(8):1754-62 PMID: 25772027 PMCID: PMC4527886 SCOPUS ID: 2-s2.0-84938991869 03/17/2015       36 Citations
  • Identification and utilization of donor and recipient genetic variants to predict survival after HCT: are we ready for primetime? (Sucheston-Campbell LE, Clay A, McCarthy PL, Zhu Q, Preus L, Pasquini M, Onel K, Hahn T) Curr Hematol Malig Rep 2015 Mar;10(1):45-58 PMID: 25700678 PMCID: PMC4352187 SCOPUS ID: 2-s2.0-84925534523 02/24/2015       9 Citations
  • Five hematologic tests and treatments to question. (Hicks LK, Bering H, Carson KR, Haynes AE, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Panepinto JA, Pasquini MC, Rajasekhar A, Sarode R, Wood WA) Hematology Am Soc Hematol Educ Program 2014 Dec 05;2014(1):599-603 PMID: 25696917 SCOPUS ID: 2-s2.0-84937557949 02/20/2015       5 Citations
  • Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation. (Chen YB, Lane AA, Logan B, Zhu X, Akpek G, Aljurf M, Artz A, Bredeson CN, Cooke KR, Ho VT, Lazarus HM, Olsson R, Saber W, McCarthy P, Pasquini MC) Biol Blood Marrow Transplant 2015 Jun;21(6):1046-1053 PMID: 25687795 PMCID: PMC4426014 SCOPUS ID: 2-s2.0-84943454051 02/18/2015       57 Citations
  • Guidelines for defining and implementing standard episode of care for hematopoietic stem cell transplantation within the context of clinical trials. (Majhail NS, Giralt S, Bonagura A, Crawford S, Farnia S, Omel JL, Pasquini M, Saber W, LeMaistre CF) Biol Blood Marrow Transplant 2015 Apr;21(4):583-8 PMID: 25639771 SCOPUS ID: 2-s2.0-84924237100 02/03/2015       9 Citations
  • Superior efficacy but higher cost of plerixafor and abbreviated-course G-CSF for mobilizing hematopoietic progenitor cells (HPC) in AL amyloidosis. (Dhakal B, D'Souza A, Arce-Lara C, Pasquini M, Saber W, Falvo F, Esselman J, Zellner K, Fenske T, Hari PN, Hamadani M) Bone Marrow Transplant 2015 Apr;50(4):610-2 PMID: 25621807 SCOPUS ID: 2-s2.0-84926418285 01/27/2015       3 Citations
  • A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality. (MacMillan ML, Robin M, Harris AC, DeFor TE, Martin PJ, Alousi A, Ho VT, Bolaños-Meade J, Ferrara JL, Jones R, Arora M, Blazar BR, Holtan SG, Jacobsohn D, Pasquini M, Socie G, Antin JH, Levine JE, Weisdorf DJ) Biol Blood Marrow Transplant 2015 Apr;21(4):761-7 PMID: 25585275 PMCID: PMC4359643 SCOPUS ID: 2-s2.0-84924230138 01/15/2015       63 Citations
  • Five hematologic tests and treatments to question. (Hicks LK, Bering H, Carson KR, Haynes AE, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Panepinto JA, Pasquini MC, Rajasekhar A, Sarode R, Wood WA) Blood 2014 Dec 04;124(24):3524-8 PMID: 25472968 SCOPUS ID: 2-s2.0-84916232429 12/05/2014       31 Citations
  • Blood and marrow transplant clinical trials network state of the Science Symposium 2014. (Appelbaum FR, Anasetti C, Antin JH, Atkins H, Davies S, Devine S, Giralt S, Heslop H, Laport G, Lee SJ, Logan B, Pasquini M, Pulsipher M, Stadtmauer E, Wingard JR, Horowitz MM) Biol Blood Marrow Transplant 2015 Feb;21(2):202-24 PMID: 25445636 PMCID: PMC4426907 SCOPUS ID: 2-s2.0-84920914015 12/03/2014       11 Citations
  • Comparison of non-myeloablative conditioning regimens for lymphoproliferative disorders. (Hong S, Le-Rademacher J, Artz A, McCarthy PL, Logan BR, Pasquini MC) Bone Marrow Transplant 2015 Mar;50(3):367-74 PMID: 25437248 PMCID: PMC4351124 SCOPUS ID: 2-s2.0-84938416290 12/02/2014       1 Citation
  • Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). (Howard CA, Fernandez-Vina MA, Appelbaum FR, Confer DL, Devine SM, Horowitz MM, Mendizabal A, Laport GG, Pasquini MC, Spellman SR) Biol Blood Marrow Transplant 2015 Jan;21(1):4-7 PMID: 25278457 PMCID: PMC4272893 SCOPUS ID: 2-s2.0-84924246712 10/04/2014       28 Citations
  • Is 'informed consent' an 'understood consent' in hematopoietic cell transplantation? (D'Souza A, Pasquini M, Spellecy R) Bone Marrow Transplant 2015 Jan;50(1):10-4 PMID: 25243618 PMCID: PMC4320584 SCOPUS ID: 2-s2.0-84920682651 09/23/2014       14 Citations
  • Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802. (Bolaños-Meade J, Logan BR, Alousi AM, Antin JH, Barowski K, Carter SL, Goldstein SC, Hexner EO, Horowitz MM, Lee SJ, Levine JE, MacMillan ML, Martin PJ, Mendizabal AM, Nakamura R, Pasquini MC, Weisdorf DJ, Westervelt P, Ho VT) Blood 2014 Nov 20;124(22):3221-7; quiz 3335 PMID: 25170121 PMCID: PMC4239331 SCOPUS ID: 2-s2.0-84911435257 08/30/2014       35 Citations
  • Plerixafor and abbreviated-course granulocyte colony-stimulating factor for mobilizing hematopoietic progenitor cells in light chain amyloidosis. (Dhakal B, Strouse C, D'Souza A, Arce-Lara C, Esselman J, Eastwood D, Pasquini M, Saber W, Drobyski W, Rizzo JD, Hari PN, Hamadani M) Biol Blood Marrow Transplant 2014 Dec;20(12):1926-31 PMID: 25111581 SCOPUS ID: 2-s2.0-84912142377 08/12/2014       15 Citations
  • Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT. (Cutler C, Logan B, Nakamura R, Johnston L, Choi S, Porter D, Hogan WJ, Pasquini M, MacMillan ML, Hsu JW, Waller EK, Grupp S, McCarthy P, Wu J, Hu ZH, Carter SL, Horowitz MM, Antin JH) Blood 2014 Aug 21;124(8):1372-7 PMID: 24982504 PMCID: PMC4141519 SCOPUS ID: 2-s2.0-84907357105 07/02/2014       76 Citations
  • Acute graft-versus-host disease: a bench-to-bedside update. (Holtan SG, Pasquini M, Weisdorf DJ) Blood 2014 Jul 17;124(3):363-73 PMID: 24914140 PMCID: PMC4102709 06/11/2014       91 Citations
  • Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts. (Aljurf M, Rizzo JD, Mohty M, Hussain F, Madrigal A, Pasquini MC, Passweg J, Chaudhri N, Ghavamzadeh A, Solh HE, Atsuta Y, Szer J, Kodera Y, Niederweiser D, Gratwohl A, Horowitz MM) Bone Marrow Transplant 2014 Aug;49(8):1016-21 PMID: 24777183 SCOPUS ID: 2-s2.0-84905686615 04/30/2014       14 Citations
  • Lenalidomide maintenance for high-risk multiple myeloma after allogeneic hematopoietic cell transplantation. (Alsina M, Becker PS, Zhong X, Adams A, Hari P, Rowley S, Stadtmauer EA, Vesole DH, Logan B, Weisdorf D, Qazilbash M, Popplewell LL, McClune B, Bensinger W, Riches M, Giralt SA, Pasquini MC, Resource for Clinical Investigation in Blood and Marrow Transplantation) Biol Blood Marrow Transplant 2014 Aug;20(8):1183-9 PMID: 24769014 PMCID: PMC5036168 SCOPUS ID: 2-s2.0-84904068423 04/29/2014       46 Citations
  • Allogeneic hematopoietic cell transplant for acute myeloid leukemia: Current state in 2013 and future directions. (Kanate AS, Pasquini MC, Hari PN, Hamadani M) World J Stem Cells 2014 Apr 26;6(2):69-81 PMID: 24772235 PMCID: PMC3999783 04/29/2014    
  • Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation. (Aplenc R, Zhang MJ, Sung L, Zhu X, Ho VT, Cooke K, Dvorak C, Hale G, Isola LM, Lazarus HM, McCarthy PL, Olsson R, Pulsipher M, Pasquini MC, Bunin N, Regimen-Related Toxicity Working Committee, Center for International Blood and Marrow Transplant Research) Blood 2014 May 29;123(22):3504-11 PMID: 24711663 PMCID: PMC4041168 SCOPUS ID: 2-s2.0-84901721624 04/09/2014       14 Citations
  • Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma. (Saad A, Mahindra A, Zhang MJ, Zhong X, Costa LJ, Dispenzieri A, Drobyski WR, Freytes CO, Gale RP, Gasparetto CJ, Holmberg LA, Kamble RT, Krishnan AY, Kyle RA, Marks D, Nishihori T, Pasquini MC, Ramanathan M, Lonial S, Savani BN, Saber W, Sharma M, Sorror ML, Wirk BM, Hari PN) Biol Blood Marrow Transplant 2014 Mar;20(3):402-408.e1 PMID: 24342394 PMCID: PMC3961011 SCOPUS ID: 2-s2.0-84896811241 12/18/2013       38 Citations
  • The ASH Choosing Wisely®campaign: five hematologic tests and treatments to question. (Hicks LK, Bering H, Carson KR, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Pasquini M, Sarode R, Solberg L Jr, Haynes AE, Crowther MA) Hematology Am Soc Hematol Educ Program 2013;2013:9-14 PMID: 24319155 SCOPUS ID: 2-s2.0-84904720715 12/10/2013       16 Citations
  • The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question. (Hicks LK, Bering H, Carson KR, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Pasquini M, Sarode R, Solberg L Jr, Haynes AE, Crowther MA) Blood 2013 Dec 05;122(24):3879-83 PMID: 24307720 SCOPUS ID: 2-s2.0-84891119402 12/07/2013       77 Citations
  • Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation. (Bredeson C, LeRademacher J, Kato K, Dipersio JF, Agura E, Devine SM, Appelbaum FR, Tomblyn MR, Laport GG, Zhu X, McCarthy PL, Ho VT, Cooke KR, Armstrong E, Smith A, Rizzo JD, Burkart JM, Pasquini MC) Blood 2013 Dec 05;122(24):3871-8 PMID: 24081656 PMCID: PMC3854109 SCOPUS ID: 2-s2.0-84887535514 10/02/2013       73 Citations
  • Divergent effects of novel immunomodulatory agents and cyclophosphamide on the risk of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma. (Cornell RF, Hari P, Zhang MJ, Zhong X, Thompson J, Fenske TS, Horowitz MM, Komorowski R, Palmer J, Pasquini MC, Rizzo JD, Saber W, Thomas M, Drobyski WR) Biol Blood Marrow Transplant 2013 Sep;19(9):1368-73 PMID: 23806770 SCOPUS ID: 2-s2.0-84882809747 06/29/2013       13 Citations
  • Anatomy of a successful practice-changing study: a Blood and Marrow Transplantation Clinical Trials Network-National Cancer Institute Cooperative Group collaboration. (Giralt S, McCarthy PL, Anderson KC, Carter SL, Richardson PG, Rajkumar SV, Laport GG, Stadtmauer EA, Pasquini MC, Horowitz MM) Biol Blood Marrow Transplant 2013 Jun;19(6):858-9 PMID: 23545332 PMCID: PMC4426902 SCOPUS ID: 2-s2.0-84877878693 04/03/2013       1 Citation
  • Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study. (Gratwohl A, Baldomero H, Gratwohl M, Aljurf M, Bouzas LF, Horowitz M, Kodera Y, Lipton J, Iida M, Pasquini MC, Passweg J, Szer J, Madrigal A, Frauendorfer K, Niederwieser D, Worldwide Network of Blood and Marrow Transplantation (WBMT)) Haematologica 2013 Aug;98(8):1282-90 PMID: 23508009 PMCID: PMC3729910 SCOPUS ID: 2-s2.0-84880968130 03/20/2013       70 Citations
  • 2013 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders. (Pasquini M, Wang Z, Horowitz MM, Gale RP) Clin Transpl 2013:187-97 PMID: 25095508 SCOPUS ID: 2-s2.0-84906956354 01/01/2013       27 Citations
  • Effects of spleen status on early outcomes after hematopoietic cell transplantation. (Akpek G, Pasquini MC, Logan B, Agovi MA, Lazarus HM, Marks DI, Bornhaeüser M, Ringdén O, Maziarz RT, Gupta V, Popat U, Maharaj D, Bolwell BJ, Rizzo JD, Ballen KK, Cooke KR, McCarthy PL, Ho VT) Bone Marrow Transplant 2013 Jun;48(6):825-31 PMID: 23222382 PMCID: PMC3606905 SCOPUS ID: 2-s2.0-84879072722 12/12/2012       26 Citations
  • Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantation. (Pasquini MC, Devine S, Mendizabal A, Baden LR, Wingard JR, Lazarus HM, Appelbaum FR, Keever-Taylor CA, Horowitz MM, Carter S, O'Reilly RJ, Soiffer RJ) J Clin Oncol 2012 Sep 10;30(26):3194-201 PMID: 22869882 PMCID: PMC3434978 SCOPUS ID: 2-s2.0-84866554399 08/08/2012       90 Citations
  • Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research. (Pasquini MC, Voltarelli J, Atkins HL, Hamerschlak N, Zhong X, Ahn KW, Sullivan KM, Carrum G, Andrey J, Bredeson CN, Cairo M, Gale RP, Hahn T, Storek J, Horowitz MM, McSweeney PA, Griffith LM, Muraro PA, Pavletic SZ, Nash RA) Biol Blood Marrow Transplant 2012 Oct;18(10):1471-8 PMID: 22705497 PMCID: PMC3950896 SCOPUS ID: 2-s2.0-84866174558 06/19/2012       34 Citations
  • Lenalidomide after stem-cell transplantation for multiple myeloma. (McCarthy PL, Owzar K, Hofmeister CC, Hurd DD, Hassoun H, Richardson PG, Giralt S, Stadtmauer EA, Weisdorf DJ, Vij R, Moreb JS, Callander NS, Van Besien K, Gentile T, Isola L, Maziarz RT, Gabriel DA, Bashey A, Landau H, Martin T, Qazilbash MH, Levitan D, McClune B, Schlossman R, Hars V, Postiglione J, Jiang C, Bennett E, Barry S, Bressler L, Kelly M, Seiler M, Rosenbaum C, Hari P, Pasquini MC, Horowitz MM, Shea TC, Devine SM, Anderson KC, Linker C) N Engl J Med 2012 May 10;366(19):1770-81 PMID: 22571201 PMCID: PMC3744390 05/11/2012    
  • Hematopoietic cell transplantation in Latin America. (Eckrich M, Pasquini M) Hematology 2012 Apr;17 Suppl 1:S189-91 PMID: 22507817 SCOPUS ID: 2-s2.0-84859778693 04/25/2012       7 Citations
  • Hematopoietic cell transplantation for chronic myeloid leukemia in developing countries: perspectives from Latin America in the post-tyrosine kinase inhibitor era. (Pasquini MC) Hematology 2012 Apr;17 Suppl 1:S79-82 PMID: 22507787 SCOPUS ID: 2-s2.0-84859747161 04/25/2012       8 Citations
  • A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper. (Saccardi R, Freedman MS, Sormani MP, Atkins H, Farge D, Griffith LM, Kraft G, Mancardi GL, Nash R, Pasquini M, Martin R, Muraro PA, European Blood and Marrow Transplantation Group, Center for International Blood and Marrow Research, HSCT in MS International Study Group) Mult Scler 2012 Jun;18(6):825-34 PMID: 22383228 PMCID: PMC3389500 SCOPUS ID: 2-s2.0-84861802589 03/03/2012       59 Citations
  • Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial. (Krishnan A, Pasquini MC, Logan B, Stadtmauer EA, Vesole DH, Alyea E 3rd, Antin JH, Comenzo R, Goodman S, Hari P, Laport G, Qazilbash MH, Rowley S, Sahebi F, Somlo G, Vogl DT, Weisdorf D, Ewell M, Wu J, Geller NL, Horowitz MM, Giralt S, Maloney DG, Blood Marrow Transplant Clinical Trials Network (BMT CTN)) Lancet Oncol 2011 Dec;12(13):1195-203 PMID: 21962393 PMCID: PMC3611089 SCOPUS ID: 2-s2.0-82555179157 10/04/2011       184 Citations
  • Characteristics of CliniMACS® System CD34-enriched T cell-depleted grafts in a multicenter trial for acute myeloid leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) protocol 0303. (Keever-Taylor CA, Devine SM, Soiffer RJ, Mendizabal A, Carter S, Pasquini MC, Hari PN, Stein A, Lazarus HM, Linker C, Goldstein SC, Stadtmauer EA, O'Reilly RJ) Biol Blood Marrow Transplant 2012 May;18(5):690-7 PMID: 21875505 PMCID: PMC3762249 SCOPUS ID: 2-s2.0-84859878721 08/31/2011       35 Citations
  • Tocilizumab for the treatment of steroid refractory graft-versus-host disease. (Drobyski WR, Pasquini M, Kovatovic K, Palmer J, Douglas Rizzo J, Saad A, Saber W, Hari P) Biol Blood Marrow Transplant 2011 Dec;17(12):1862-8 PMID: 21745454 PMCID: PMC3716013 SCOPUS ID: 2-s2.0-81255163590 07/13/2011       58 Citations
  • Role of reduced intensity conditioning in allogeneic hematopoietic cell transplantation for patients with multiple myeloma. (Nishihori T, Kharfan-Dabaja MA, Ochoa-Bayona JL, Bazarbachi A, Pasquini M, Alsina M) Hematol Oncol Stem Cell Ther 2011;4(1):1-9 PMID: 21460601 04/05/2011    
  • Trends of hematopoietic stem cell transplantation in the Eastern Mediterranean region, 1984-2007. (Ahmed SO, Ghavamzadeh A, Zaidi SZ, Baldomero H, Pasquini MC, Hussain F, Alimoghaddam K, Almohareb F, Ayas M, Hamidieh A, Mahmoud HK, Elhaddad A, Ben Othman T, Abdelkefi A, Sarhan M, Abdel-Rahman F, Adil S, Alkindi S, Bazarbachi A, Benchekroun S, Niederwieser D, Horowitz M, Gratwohl A, El Solh H, Aljurf M) Biol Blood Marrow Transplant 2011 Sep;17(9):1352-61 PMID: 21440654 PMCID: PMC3371191 SCOPUS ID: 2-s2.0-79961002454 03/29/2011       11 Citations
  • Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials network protocol 0303. (Devine SM, Carter S, Soiffer RJ, Pasquini MC, Hari PN, Stein A, Lazarus HM, Linker C, Stadtmauer EA, Alyea EP 3rd, Keever-Taylor CA, O'Reilly RJ) Biol Blood Marrow Transplant 2011 Sep;17(9):1343-51 PMID: 21320619 PMCID: PMC3150599 SCOPUS ID: 2-s2.0-79960270124 02/16/2011       84 Citations
  • Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made? (Horan JT, Logan BR, Agovi-Johnson MA, Lazarus HM, Bacigalupo AA, Ballen KK, Bredeson CN, Carabasi MH, Gupta V, Hale GA, Khoury HJ, Juckett MB, Litzow MR, Martino R, McCarthy PL, Smith FO, Rizzo JD, Pasquini MC) J Clin Oncol 2011 Mar 01;29(7):805-13 PMID: 21220593 PMCID: PMC3068057 SCOPUS ID: 2-s2.0-79952356420 01/12/2011       102 Citations
  • Role of reduced intensity conditioning in allogeneic hematopoietic cell transplantation for patients with multiple myeloma (Nishihori T, Kharfan-Dabaja MA, Ochoa-Bayona JL, Bazarbachi A, Pasquini M, Alsina M) Hematology/ Oncology and Stem Cell Therapy 2011;4(1):1-9 SCOPUS ID: 2-s2.0-79956075049 01/01/2011    
  • Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic anemia. (Barker CC, Agovi MA, Logan B, Lazarus HM, Ballen KK, Gupta V, Hale GA, Frangoul H, Ho V, Rizzo JD, Pasquini MC, Regimen-Related Toxicity Writing Committee, Center for International Blood and Marrow Transplant Research) Biol Blood Marrow Transplant 2011 May;17(5):737-44 PMID: 20817111 PMCID: PMC3035737 SCOPUS ID: 2-s2.0-79954570682 09/08/2010       18 Citations
  • Access to hematopoietic stem cell transplantation: effect of race and sex. (Joshua TV, Rizzo JD, Zhang MJ, Hari PN, Kurian S, Pasquini M, Majhail NS, Lee SJ, Horowitz MM) Cancer 2010 Jul 15;116(14):3469-76 PMID: 20564154 PMCID: PMC3153958 SCOPUS ID: 2-s2.0-77954889709 06/22/2010       56 Citations
  • Hematopoietic stem cell transplantation: a global perspective. (Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A, Szer J, Lipton J, Schwendener A, Gratwohl M, Frauendorfer K, Niederwieser D, Horowitz M, Kodera Y, Worldwide Network of Blood and Marrow Transplantation) JAMA 2010 Apr 28;303(16):1617-24 PMID: 20424252 PMCID: PMC3219875 SCOPUS ID: 2-s2.0-77951623928 04/29/2010       365 Citations
  • Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults. (Navarro WH, Agovi MA, Logan BR, Ballen K, Bolwell BJ, Frangoul H, Gupta V, Hahn T, Ho VT, Juckett M, Lazarus HM, Litzow MR, Liesveld JL, Moreb JS, Marks DI, McCarthy PL, Pasquini MC, Rizzo JD) Biol Blood Marrow Transplant 2010 Oct;16(10):1442-50 PMID: 20412867 PMCID: PMC2933950 SCOPUS ID: 2-s2.0-77956270036 04/24/2010       49 Citations
  • NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Transplantation. (Pavletic SZ, Kumar S, Mohty M, de Lima M, Foran JM, Pasquini M, Zhang MJ, Giralt S, Bishop MR, Weisdorf D) Biol Blood Marrow Transplant 2010 Jul;16(7):871-90 PMID: 20399876 PMCID: PMC2916039 SCOPUS ID: 2-s2.0-77953587073 04/20/2010       66 Citations
  • Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studies. (Pasquini MC, Griffith LM, Arnold DL, Atkins HL, Bowen JD, Chen JT, Freedman MS, Kraft GH, Mancardi GL, Martin R, Muraro PA, Nash RA, Racke MK, Storek J, Saccardi R) Biol Blood Marrow Transplant 2010 Aug;16(8):1076-83 PMID: 20304084 PMCID: PMC2897916 SCOPUS ID: 2-s2.0-77954315037 03/23/2010       33 Citations
  • Second unrelated donor hematopoietic cell transplantation for primary graft failure. (Schriber J, Agovi MA, Ho V, Ballen KK, Bacigalupo A, Lazarus HM, Bredeson CN, Gupta V, Maziarz RT, Hale GA, Litzow MR, Logan B, Bornhauser M, Giller RH, Isola L, Marks DI, Rizzo JD, Pasquini MC) Biol Blood Marrow Transplant 2010 Aug;16(8):1099-106 PMID: 20172038 PMCID: PMC2897953 SCOPUS ID: 2-s2.0-77954316434 02/23/2010       41 Citations
  • 2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders. (Pasquini MC, Wang Z, Horowitz MM, Gale RP) Clin Transpl 2010:87-105 PMID: 21696033 SCOPUS ID: 2-s2.0-79960030746 01/01/2010       103 Citations
  • Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. (Litzow MR, Tarima S, Pérez WS, Bolwell BJ, Cairo MS, Camitta BM, Cutler CS, de Lima M, Dipersio JF, Gale RP, Keating A, Lazarus HM, Luger S, Marks DI, Maziarz RT, McCarthy PL, Pasquini MC, Phillips GL, Rizzo JD, Sierra J, Tallman MS, Weisdorf DJ) Blood 2010 Mar 04;115(9):1850-7 PMID: 20032503 PMCID: PMC2832815 SCOPUS ID: 2-s2.0-77950361766 12/25/2009       133 Citations
  • Defining the intensity of conditioning regimens: working definitions. (Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, Apperley J, Slavin S, Pasquini M, Sandmaier BM, Barrett J, Blaise D, Lowski R, Horowitz M) Biol Blood Marrow Transplant 2009 Dec;15(12):1628-33 PMID: 19896087 PMCID: PMC2861656 SCOPUS ID: 2-s2.0-70350764819 11/10/2009       670 Citations
  • Re: Tandem vs single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis. (Giralt S, Vesole DH, Somlo G, Krishnan A, Stadtmauer E, Mccarthy P, Pasquini MC, Blood and Marrow Transplant Clinical Trials Network Multiple Myeloma Working Group) J Natl Cancer Inst 2009 Jul 01;101(13):964; author reply 966-7 PMID: 19535777 PMCID: PMC4415058 SCOPUS ID: 2-s2.0-67650075366 06/19/2009       5 Citations
  • Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network. (Alousi AM, Weisdorf DJ, Logan BR, Bolaños-Meade J, Carter S, Difronzo N, Pasquini M, Goldstein SC, Ho VT, Hayes-Lattin B, Wingard JR, Horowitz MM, Levine JE, Blood and Marrow Transplant Clinical Trials Network) Blood 2009 Jul 16;114(3):511-7 PMID: 19443659 PMCID: PMC2713466 SCOPUS ID: 2-s2.0-70149109879 05/16/2009       145 Citations
  • Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. (Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, Sandmaier B) Biol Blood Marrow Transplant 2009 Mar;15(3):367-9 PMID: 19203728 PMCID: PMC3110087 SCOPUS ID: 2-s2.0-59349093509 02/11/2009       363 Citations
  • HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens. (Pasquini R, Carreras J, Pasquini MC, Camitta BM, Fasth AL, Hale GA, Harris RE, Marsh JC, Robinson AJ, Zhang MJ, Eapen M, Wagner JE) Biol Blood Marrow Transplant 2008 Oct;14(10):1141-1147 PMID: 18804044 PMCID: PMC2581414 SCOPUS ID: 2-s2.0-51649094272 09/23/2008       42 Citations
  • Impact of graft-versus-host disease on survival. (Pasquini MC) Best Pract Res Clin Haematol 2008 Jun;21(2):193-204 PMID: 18503986 SCOPUS ID: 2-s2.0-44149120553 05/28/2008       31 Citations
  • On the probability of using cord blood. (Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM) Biol Blood Marrow Transplant 2008 Jun;14(6):724-5 PMID: 18489999 SCOPUS ID: 2-s2.0-43649090840 05/21/2008       4 Citations
  • Lifetime probabilities of hematopoietic stem cell transplantation in the U.S. (Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM) Biol Blood Marrow Transplant 2008 Mar;14(3):316-22 PMID: 18275898 PMCID: PMC2531159 SCOPUS ID: 2-s2.0-38949210240 02/16/2008       40 Citations
  • HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR. (Schlenk RF, Pasquini MC, Pérez WS, Zhang MJ, Krauter J, Antin JH, Bashey A, Bolwell BJ, Büchner T, Cahn JY, Cairo MS, Copelan EA, Cutler CS, Döhner H, Gale RP, Ilhan O, Lazarus HM, Liesveld JL, Litzow MR, Marks DI, Maziarz RT, McCarthy PL, Nimer SD, Sierra J, Tallman MS, Weisdorf DJ, Horowitz MM, Ganser A, CIBMTR Acute Leukemia Working Committee) Biol Blood Marrow Transplant 2008 Feb;14(2):187-96 PMID: 18215779 PMCID: PMC2531160 SCOPUS ID: 2-s2.0-38349185874 01/25/2008       35 Citations
  • Hematopoietic cell transplantation in acute promyelocytic leukemia: a comprehensive review. (Kharfan-Dabaja MA, Abou Mourad YR, Fernandez HF, Pasquini MC, Santos ES) Biol Blood Marrow Transplant 2007 Sep;13(9):997-1004 PMID: 17697961 SCOPUS ID: 2-s2.0-34547802157 08/19/2007       17 Citations
  • New questions about transplantation in multiple myeloma. (Hari P, Pasquini MC, Vesole DH) Oncology (Williston Park) 2006 Sep;20(10):1230-42; discussion 1242, 1244, 1249-50 PMID: 17024872 SCOPUS ID: 2-s2.0-34250634391 10/10/2006       3 Citations
  • Cure of multiple myeloma -- more hype, less reality. (Hari P, Pasquini MC, Vesole DH) Bone Marrow Transplant 2006 Jan;37(1):1-18 PMID: 16258534 SCOPUS ID: 2-s2.0-31344453763 11/01/2005       24 Citations
  • The human Penumbra gene is mapped to a region on chromosome 7 frequently deleted in myeloid malignancies. (Chen Z, Pasquini M, Hong B, DeHart S, Heikens M, Tsai S) Cancer Genet Cytogenet 2005 Oct 15;162(2):95-8 PMID: 16213355 10/11/2005       13 Citations
  • Bone marrow transplantation for diamond-blackfan anemia. (Roy V, Pérez WS, Eapen M, Marsh JC, Pasquini M, Pasquini R, Mustafa MM, Bredeson CN, Non-Malignant Marrow Disorders Working Committee of the International Bone Marrow Transplant Registry) Biol Blood Marrow Transplant 2005 Aug;11(8):600-8 PMID: 16041310 SCOPUS ID: 2-s2.0-22344441866 07/26/2005       39 Citations
  • Localization of the murine homolog of the anaplastic lymphoma kinase (AlK) gene on mouse chromosome 17. (Mathew P, Morris SW, Kane JR, Shurtleff SA, Pasquini M, Jenkins NA, Gilbert DJ, Copeland NG) Cytogenet Cell Genet 1995;70(1-2):143-4 PMID: 7736780 01/01/1995       11 Citations
  • Last update: 09/16/2019
    jenkins-FCD Prod-388 89e904233d719332173309c68ab82b0b2a78a3a7